Navigation Links
BioMedix™ Receives Patent for Its Innovative Collaborative Care Business Method
Date:7/21/2011

ST. PAUL, Minn., July 21, 2011 /PRNewswire/ -- BioMedix™, a leader in providing integrated Health Information Technology (HIT) products and services, has been awarded a U.S. Patent recognizing its innovative solutions and methods for detecting and managing cardiovascular disease.

On July 19, 2011, the United States Patent & Trademark Office issued U.S. Patent Number 7,983,930, entitled "System and Method for Testing for Cardiovascular Disease," crediting BioMedix™ President & CEO John Romans as inventor. The patent is now part of the growing portfolio of BioMedix™ intellectual property on innovative medical technologies, addressing testing, diagnosis and administrative processing across remote locations. The underlying concept, comprised of a collaborative care model utilizing the integrated suite of BioMedix™ solutions, facilitates partnership between primary care facilities and specialists, taking advantage of the specialists' expertise while still allowing testing to be easily performed at a variety of accessible test locations.

"This development allows specialists to have a virtual presence in every primary care setting, enabling improved care through cost-effective coordination and collaboration of physicians in different physical locations," stated John Romans.

The initial application of this invention has supported the improved detection, treatment and management of an under-diagnosed and costly vascular condition called Peripheral Artery Disease (P.A.D.). The BioMedix™ collaborative care network reduces time and travel for patient treatment while supporting improved patient outcomes. As part of this advanced web-based platform, BioMedix™ PADnet™ Disease Management System 2.0 provides a turnkey collaborative care solution for finding and managing patients with vascular disease utilizing the BioMedix™ PADnet™+, a non-invasive device for in-office testing. With a disease detection network made up of local hub-and-spoke networks across the country, BioMedix™ products and initiatives aim to address gaps in healthcare and disease detection.

Austen Zuege, shareholder at the intellectual property law firm Kinney & Lange, P.A. in Minneapolis said, "I am pleased to see the issuance of this patent, which demonstrates the high level of innovation at BioMedix™."

About BioMedix™

BioMedix™ is a leader in Health Information Technology (HIT) software, products and services that connect Podiatric Physicians, Primary Care Physicians, vascular labs, vascular specialists and healthcare systems in a continuum of collaborative care. We provide the only integrated suite of hardware, software and online services designed to cost-effectively detect vascular disease. Our award-winning suite of medical devices, advanced practice management and Electronic Health Record (EHR) software and web-based solutions give providers a more complete view of patient care. For more information about BioMedix™ products, call 877-854-0014 or log on to www.BioMedix.com.


'/>"/>
SOURCE BioMedix
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMedix™ Announces John Martin, MD, FACS, as Medical Director
2. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
3. Agendia Receives €1.27 Million in Funding from the EUs Seventh Framework Programme
4. Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
5. Perrigo Receives FDA Approval to Market Coated Cinnamon Nicotine Gum
6. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
7. UCLA Receives Six UC Health Quality Grants to Improve Hospital Care
8. Sequana Medical Receives CE Mark Approval for the ALFApump™ System and Adds Key Executive to Team
9. Chartwell Pharmaceuticals Receives Official FDA Registration
10. GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
11. Sonitus Medical Receives Second FDA Clearance for SoundBite™ Hearing System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):